-
1 Comment
Materialise NV is currently in a long term downtrend where the price is trading 45.0% below its 200 day moving average.
From a valuation standpoint, the stock is 62.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 9.6.
Materialise NV's total revenue sank by 10.7% to $45M since the same quarter in the previous year.
Its net income has dropped by 261.5% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 503.0% to $12M since the same quarter in the previous year.
Based on the above factors, Materialise NV gets an overall score of 2/5.
ISIN | US57667T1007 |
---|---|
CurrencyCode | USD |
Exchange | NASDAQ |
Industry | Software-Application |
Sector | Technology |
Dividend Yield | 0.0% |
---|---|
PE Ratio | None |
Market Cap | 470M |
Target Price | 12.66 |
Beta | 0.8 |
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MTLS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024